The aberrant activation of the phosphoinositide 3-kinase (PI3K)/ protein kinase B (AKT) pathway is common in pancreatic ductal adenocarcinomas (PDAC). This evidence concerns the gene AKT1 and pancreatic ductal adenocarcinoma.